Avanos Medical, Inc.
AVNS
$12.47
$0.040.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.15% | -0.01% | -0.03% | -0.58% | -1.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.15% | -0.01% | -0.03% | -0.58% | -1.58% |
| Cost of Revenue | 4.39% | 3.13% | 3.86% | 3.13% | 1.28% |
| Gross Profit | 0.42% | -2.40% | -2.91% | -3.28% | -3.68% |
| SG&A Expenses | -5.58% | -9.96% | -9.92% | -2.15% | 1.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.09% | 0.00% | 16.22% | -30.30% | 1,550.00% |
| Total Operating Expenses | -1.02% | -3.91% | -3.87% | -0.34% | 1.33% |
| Operating Income | 90.17% | 93.75% | 98.44% | -4.64% | -45.20% |
| Income Before Tax | -5,005.06% | 1,144.00% | 37.25% | -88.21% | -129.59% |
| Income Tax Expenses | -950.00% | -49.43% | 337.50% | -17.31% | -61.54% |
| Earnings from Continuing Operations | -3,802.02% | 293.75% | -18.60% | -109.04% | -146.05% |
| Earnings from Discontinued Operations | 88.82% | 86.43% | 101.57% | -325.28% | -278.97% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -534.47% | 128.34% | 121.39% | -239.46% | -222.38% |
| EBIT | 90.17% | 93.75% | 98.44% | -4.64% | -45.20% |
| EBITDA | 34.53% | 35.81% | 25.88% | -8.80% | -26.00% |
| EPS Basic | -546.92% | 128.82% | 121.93% | -238.98% | -222.11% |
| Normalized Basic EPS | 232.16% | 203.11% | 189.12% | -9.53% | -66.34% |
| EPS Diluted | -545.74% | 127.74% | 120.94% | -241.08% | -224.46% |
| Normalized Diluted EPS | 232.91% | 204.10% | 192.85% | -9.01% | -66.39% |
| Average Basic Shares Outstanding | -1.23% | -1.29% | -0.75% | -0.48% | -0.69% |
| Average Diluted Shares Outstanding | -0.64% | -0.53% | -0.53% | -0.69% | -1.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
